Abstract: Pressure sensitive adhesive having favorable adhesive, shear, liquid permeability, and release characteristics. The adhesive is a crosslinked polymerization product of a methyl/phenyl siloxane gum, dimethyl siloxane gum and a polysiloxane resin. The resulting product provides suitable adhesion to a large number of surfaces and has particular utility as an adhesive between plastic film and human skin, especially for use with transdermal therapeutic devices. The adhesive characteristic mitigates damage to underlying surfaces such as human skin tissue during adhesive removal.

Abstract: Woven pile fabrics, particularly upholstery fabrics and corduroy, characterized by a superior balance of strength and softness are back-coated utilizing an aqueous emulsion prepared by the emulsion polymerization of a vinyl ester of an alkanoic acid interpolymerized with 10 to 30% by weight ethylene; 15 to 40% by weight of a C4-C10 dialkyl maleate; to 5% by weight of copolymerizable N-methylol containing monomer; 0 to 4% by weight of an olefinically unsaturated carboxylic acid and 0 to 1% by weight of a polyethylenically unsaturated comonomer.

Abstract: A method for achieving the flame retardancy of polypropylene fiber and for fabrics which include such fibers has been devised which has a low add-on finish. The finish comprises a mixture containing a bromochlorinated paraffin having a high concentration of bromine, up to 80% by weight, but, notwithstanding low add-on, the invention will produce an extremely effective fire retardancy where the bromine and chlorine constituents equal 20% and 40% respecively by weight of the bromochlorinated paraffin. Antimony oxide, preferably a antimony pentoxide is used, having a preferred particulate size in the range of 30-50 millimicrons. The quantity of antimony oxide to be used may be 1/3 mole to 1 mole of bromine. After the bromochlorinated paraffin is combined with emulsifiers to form a stable premix, the premix and antimony pentoxide are preferably combined with a binder consisting of an ethylacrylate latex.

Abstract: A cleansing and disinfecting composition comprising an alkaline per-salt and a positively charged phase-transfer agent and absorbent materials, such as sponges, impregnated therewith. The composition preferably also contains one or more surfactants. The alkaline per-salt is an alkaline water-soluble salt having hydrogen peroxide of crystallization. The positively charged phase-transfer agent is preferably a quaternary ammonium salt. The composition may be formulated as a cream, a bulk powder, a solution or tablets. It ay also be incorporated in wipes, sponges and brushes. In one embodiment, one surface of the impregnated sponge is an abrasive material. The compositions of this invention find utility in health care, as disinfectants in surgical applications, and as cleansing and decontaminating agents.

Abstract: The process results in an adhesive plaster for the transdermal adminstration of pharmaceutical, in particular heat-sensitive, active substances, composed of an adhesive layer, a backing layer, a matrix layer containing the active substances, and a protective layer. The flux of active substance release is controlled by its diffusion from the matrix layer. The latter is produced by the hot melt method, by mixing an ethylene/vinyl acetate copolymer and an involatile, hydrophobic excipient which is miscible with the latter, is compatible with the active substance and is tolerated by the skin, for example isopropyl myristate or a triglyceride, at the melting point of the mixture, and incorporation therein of a solution or dispersion of the active substance in a small amount of the same excipient.

Abstract: A tamper evident pharmaceutical capsule which contains an active agent. The capsule is coated on its external surfaces to provide an indication of tampering.

Abstract: The agent or agents of the invention, taken alone or as mixtures, belong to the family of compounds used in perfumery for their odoriferous properties presenting additionally a vapor tension lower or equal to 4 Pa at 25.degree. C.

Abstract: An osmotic dosage system is disclosed for delivering the therapeutically beneficial drug doxazosin to an environment of use over time.

Abstract: Method and apparatus for applying a curable material having variable curing characteristics to a surface in a defined application cycle which includes the steps of applying only a first slow curing component to the surface of an article at least at the beginning or at the end of an application cycle and applying during the remaining part of the application cycle a mixture of the slow curing component and a curing agent which accelerates the curing of the first component.

Abstract: A composition which includes (a) at least one insecticide selected from the group consisting of organic phosphorous insecticides, carbamate insecticides and pyrethroid insecticides in a microencapsulated form, (b) crystalline cellulose and (c) crop product powders, which is useful as a bait for control of noxious insects.

Abstract: This invention relates to the transdermal administration of compounds of general formula I ##STR1## wherein R.sub.1, R.sub.2 and X have the meanings given in the text, and to a therapeutic system for the transdermal administration of this compound.

Abstract: A device for protecting the beauty rims of ceilng-mounted water sprinklers comprises a shield member having a closed end removably attached to one end of an elongate handle. The shield member has an open end, the interior surface of which may be provided with a ring of adhesive material. In one preferred embodiment, the shield member is attachable to the beauty rim solely by the adhesive material. In another preferred embodiment, the shield member has a plurality of longitudinal, inwardly-directed ribs that are frictionally engageable against the protective receptacle within the beauty rim of the sprinkler on which the shield is installed.

Abstract: A water-soluble, foamable, insecticidally-active composition is disclosed. Also disclosed are methods for producing such a composition. The water-soluble, foamable, insecticidally-active composition comprises an aqueous phase, an insecticidally-active toxicant, and a foam-causing ingredient. The aqueous phase comprises water. The foam-causing ingredient must be capable of dispersing the insecticidally-active toxicant throughout the aqueous phase, to produce a toxicant-in-water dispersion. The foam-causing ingredient is present in an amount effective to enable the toxicant-in-water dispersion to form-in-place a water-soluble and insecticidally-active foam. The water-soluble aspect of the foam allows dissolving the foam (utilizing sufficient water) when desired.

Abstract: A controlled release pharmaceutical preparation containing a micronized gastrointestinal irritant drug, such as potassium chloride, in a non-toxic protective balm. An irritant/balm admixture may be formed into microparticles. Alternatively, an irritant/balm admixture, may be used as the core for microcapsules. The microparticles or microcapsules may themselves be filled into a capsule or tabletted.

Abstract: A dosage form that coadministers a drug and two percutaneous absorption enhancers to a defined area of the skin is described. The dosage form comprises a body that contains supplies of drug and enhancers and has a basal surface that contacts the area of skin and transmits the drug and enhancers to the area for absorption thereby.

Abstract: Transdermal fertility-controlling absorption polymer matrix dosage units have been developed which comprise a backing layer, an adjoining layer of a solid polymer matrix in which minimum effective daily doses of an estrogen and a progestin are microdispersed and released for transdermal absorption. Presently preferred is use of the natural estrogen, 17-beta-estradiol, and of the progestin, levonorgestrel. The units have a biologically acceptable adhesive polymer layer. The polymer matrix as well as the adhesive layer can have dispersed one or more skin permeation enhancers. Dosage units are provided which transdermally deliver at least minimum daily doses of the estrogen and progestin for multiple days, such as for one week. The invention also provides a process of fertility control using the novel polymer matrix dosage units for the first three weeks of consecutive menstrual cycles of the subject desiring fertility control.

Abstract: A repellent composition e.g. for repelling deer comprises a synthetic blend of components which are characteristic of the acid fraction obtained by a Soxhlet extraction of lion faeces followed by separation into basic, neutral and acid fractions; and felinine. The composition may comprise saturated alkanoic acids with carbon atoms in the range of 3-20; saturated aliphatic alcohols with carbon atoms in the range 14-16; various compounds containing primary or secondary amino groups and having carbon atoms in the range 3-9; a fermented egg product; a bittering agent and an adhesive agent.

Abstract: A method of inducing anorexia or nasal decongestion comprising transdermally administering an enantiomer of phenylpropanolamine is disclosed.

Abstract: An insecticidal resin coating film comprising a combination of an acrylonitrile and/or methacrylonitrile copolymer resin and an insecticidal component selected from the group consisting of specified compounds exhibits an insecticidal effect, since the compound is kept on the surface of the coating film in a state capable of exhibiting its insecticidal effect for a long period of time.

Abstract: The invention relates to a transdermal laminated pharmaceutical composition (plaster) having prolonged effect, wherein one or more storing layer(s) comprising the active ingredient, an ethylene/vinyl acetate copolymer regulating layer and an adhesive layer are applied onto the carrier.The pharmaceutical composition is prepared by coupling a carrier comprising the active ingredient with a regulating layer consisting of an ethylene/vinyl acetate copolymer foil having a vinal acetate content of 2-40 molar %. The foil is previously irradiated in a thickness of 100-300 .mu.m with a high-energy irradiation in a dose of 1-15 Mrad--preferably with electrone radiation--and thereafter stretched at 80.degree.-90.degree. C. to a thickness of 2-200 .mu.m.The system comprising the carrier and the regulating layer is subsequently coupled with an adhesive layer.